Tabula Rasa HealthCare®, Inc. (TRHC), a healthcare technology company in the field of medication safety, is coordinating an effort to help current Programs of All-Inclusive Care for the Elderly (PACE) clients with access to COVID-19 (SARS-CoV-2 RNA) testing kits. The testing kits are being made available through TRHC’s PACE pharmacy, CareKinesis®. In addition to providing PACE partners with the testing kits, TRHC’s CareKinesis pharmacy is also offering the BioIntelliSense BioSticker™ which allows PACE centers to remotely monitor patients for COVID-19 symptoms, including fever, cough, and shortness of breath. The BioSticker is the first FDA-cleared, single-use device enabling 30 days of continuous vital sign monitoring.
An affiliate of the U.S. Chamber of Commerce